EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The microbial metabolite trimethylamine N-oxide and the kidney diseases

Jin-Qi Su, Xiang-Qi Wu, Qi Wang, Bo-Yang Xie, Cui-Yan Xiao, Hong-Yong Su, Ji-Xin Tang, Cui-Wei Yao

Frontiers in Cellular and Infection Microbiology · 11.03.2025 · 15

DOI: 10.3389/fcimb.2025.1488264 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 11.03.2025. Verfasst von Jin-Qi Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Institute of Nephrology, Affiliated Hospital of Guangdo…. Hauptthemen laut MEDLINE: Methylamines, Kidney Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trimethylamine N-oxide (TMAO), a metabolite, is a co-metabolite produced by both gut microbiota and livers, originating from foods rich in choline or carnitine. Emerging evidence suggests that TMAO may play a role in the pathogenesis of various kidney diseases, including acute kidney injury and chronic kidney disease. Research has demonstrated that heightened levels of TMAO are correlated with a heightened likelihood of kidney disease advancement and cardiovascular incidents among individuals with chronic kidney disease. Furthermore, TMAO has been observed to stimulate inflammation, oxidative stress, and fibrosis in animal models of kidney disease. Mechanistically, TMAO may contribute to kidney disease pathogenesis by inhibiting autophagy, activating the NLRP3 inflammasome, and inducing mitochondrial dysfunction. Therefore, targeting TMAO may represent a promising therapeutic strategy for the treatment of kidney diseases. Future studies are needed to further investigate the role of TMAO in kidney disease pathogenesis and to develop TMAO-targeted therapies for the prevention and treatment of kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesKidney DiseasesHumansAnimalsGastrointestinal MicrobiomeRenal Insufficiency, ChronicOxidative StressInflammasomesDisease Models, AnimalAcute Kidney InjuryInflammationAutophagyKidneyNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

TMAOchronic kidney diseaseend-stage renal diseasegut microbiomeinflammatory mechanismskidney injury

Substanzen

MethylaminestrimethyloxamineInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Key Laboratory of Prevention and Management of Chronic Kidney Diseases of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.

Förderung

  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Su, J. Q., Wu, X. Q., Wang, Q., Xie, B. Y., Xiao, C. Y., Su, H. Y., Tang, J. X., & Yao, C. W. (2025). The microbial metabolite trimethylamine N-oxide and the kidney diseases. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1488264

Vancouver

Su JQ, Wu XQ, Wang Q, Xie BY, Xiao CY, Su HY, et al. The microbial metabolite trimethylamine N-oxide and the kidney diseases. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1488264

BibTeX
@article{Su2025,
  author = {Su, Jin-Qi and Wu, Xiang-Qi and Wang, Qi and Xie, Bo-Yang and Xiao, Cui-Yan and Su, Hong-Yong and Tang, Ji-Xin and Yao, Cui-Wei},
  title = {The microbial metabolite trimethylamine N-oxide and the kidney diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1488264}
}
Kostenlos starten →